Cumulus Neuroscience
Cumulus Neuroscience is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series A, 2 tracked investors.
About Cumulus Neuroscience
Based in the United Kingdom, Cumulus Neuroscience is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cumulus Neuroscience develops the NeuLogiq Platform, which uses a dry-sensor EEG headset and AI-powered tablet assessments to measure brain function across multiple domains, including cognition, mood, and language, enabling more efficient and objective data collection in neuroscience clinical trials and patient care.
Explore Cumulus Neuroscience's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.